Thanks, Evan. I mean to be clear, we're adding both more Biogen as well as more Eisai. A year ago, CEO of Eisai and I talked about the launch of Lokembi. And for the U. S, Just discussed the complexity of the launch and we've been through all that and I won't I'm sorry, I'm sorry, I'm sorry, I'm sorry, I'm sorry, I'm sorry, I'm sorry, I'm sorry, I'm sorry, I'm sorry, I'm sorry, I'm sorry, I'm sorry, I'm sorry, I'm sorry, I'm sorry, I'm sorry, I'm sorry, I'm sorry, I'm sorry, I'm sorry, I'm sorry, I'm sorry, I'm sorry, I'm sorry, I'm sorry, I'm sorry, I'm sorry, I'm sorry, I'm In addition to these neurology account specialists, you've got MSLs, you've got some Patient care navigators, you've got some people looking after KMEs in the region and There's probably for every NAS, there's another 2 or 3 people who are actually out there in the field.